LEADER 02171nam  2200553   450 
001 9910790794403321
005 20230802010809.0
010   $a1-60795-262-9
035   $a(CKB)2550000001146694
035   $a(EBL)3386954
035   $a(SSID)ssj0001042966
035   $a(PQKBManifestationID)12431424
035   $a(PQKBTitleCode)TC0001042966
035   $a(PQKBWorkID)11051073
035   $a(PQKB)10239712
035   $a(MiAaPQ)EBC3386954
035   $a(Au-PeEL)EBL3386954
035   $a(CaPaEBR)ebr10949547
035   $a(OCoLC)923336970
035   $a(EXLCZ)992550000001146694
100   $a20141016h20122012  uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aCutaneous lymphoma $ediagnosis and treatment /$feditors, John C. Hall, Brian J. Hall ; contributors, Derek Thomas Bernstein [and thirty-five others]
210  1$aShelton, Connecticut :$cPeople's Medical Publishing House,$d2012.
210  4$dİ2012
215   $a1 online resource (265 p.)
300   $aDescription based upon print version of record.
311   $a1-60795-170-3 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $a""CUTANEOUS EXTRANODAL NATURALKILLER/T-CELL LYMPHOMA""""PRIMARY CUTANEOUS PERIPHERAL T-CELLLYMPHOMA, UNSPECIFIED""; ""CUTANEOUS B-CELL LYMPHOMAS""; ""SKIN CONDITIONS CONSIDERED TO BE PRECURSORSTO CUTANEOUS LYMPHOMA""; ""CLINICAL MIMICS OF CUTANEOUS LYMPHOMA""; ""HISTOPATHOLOGIC MIMICS OFCUTANEOUS LYMPHOMA""; ""SYSTEMIC INVOLVEMENT AND EVALUATION OFCUTANEOUS T-CELL LYMPHOMA""; ""MOLECULAR GENETICS OF CUTANEOUS LYMPHOMAS""; ""FUTURE STRATEGIES IN DIAGNOSIS AND TREATMENTOF CUTANEOUS LYMPHOMAS""; ""INDEX""
606   $aLymphomas
606   $aSkin$xTumors
615  0$aLymphomas.
615  0$aSkin$xTumors.
676   $a616.99446
702   $aHall$b John C.
702   $aHall$b Brian J.
702   $aBernstein$b Derek Thomas
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910790794403321
996   $aCutaneous lymphoma$93779248
997   $aUNINA